Brief: Matinas Biopharma Announces Notification Of NYSE American Continued Listing Deficiency
22/09/2023 22:42
Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA ANNOUNCES NOTIFICATION OF NYSE AMERICAN
CONTINUED LISTING DEFICIENCY
Source text for Eikon: ID:nGNXbvYRDp
Further company coverage: MTNB.A
Recent news on Matinas BioPharma Holdings
See all newsBrief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing
Brief: Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026
Brief: Matinas Biopharma Holdings Inc - CFO Keith Kucinski Resigns Effective January 17, 2026 - SEC Filing
Brief: Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma
Brief: Matinas BioPharma Appoints Seasoned Biotech Leaders To Board Of Directors